Statistically significant (p<0.0001) and clinically meaningful improvement in Hamilton Anxiety Rating Scale (“HAM-A”) of ~10 ...
Q32 Bio (QTTB) announced topline results from the SIGNAL-AA Phase 2a signal finding clinical trial evaluating bempikibart, or ADX-914, which identified encouraging clinical activity in patients with ...
Discusses Phase II Results for HLP004 in Generalized Anxiety Disorder March 5, 2026 7:30 AM ESTCompany ParticipantsMichael Cola - ...
Why You Can’t Just Use a Spectrum Analyzer Industry has an increasing demand for spectrally pure signals in applications such as imaging radar, mobile communications, satellite communications, weather ...
Parameter estimation of polynomial phase signals (PPS) constitutes a vital area of signal processing, wherein the objective is to accurately determine the coefficients of a polynomial function that ...
Schrödinger's SGR-1505 Phase 1 data shows encouraging safety and niche efficacy, especially in BTKi-resistant Waldenström macroglobulinemia patients. Despite a headline 22% ORR, the nuanced data ...
IDeate-PanTumor02: A phase 1b/2 study to evaluate the efficacy and safety of ifinatamab deruxtecan (I-DXd) in patients (pts) with recurrent or metastatic solid tumors. This is an ASCO Meeting Abstract ...
Figure 1 depicts the nature of the information provided by measuring a signal in the time domain vs. the frequency domain. Both provide insight into the content of the signal and possible approaches ...
QurAlis intends to advance QRL-101 into Phase 2 proof-of-concept clinical trials as a potentially best-in-class treatment for both DEE and ALS QurAlis Corporation (“QurAlis”), a clinical-stage ...
(UroToday.com) The 2026 GU ASCO annual meeting featured a kidney cancer trials in progress session and a presentation by Dr. Laurence Albiges discussing REJOICE-PanTumor01, a phase 2 signal-seeking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results